Literature DB >> 7854052

Organization of the mouse 5-HT3 receptor gene and functional expression of two splice variants.

P Werner1, E Kawashima, J Reid, N Hussy, K Lundström, G Buell, Y Humbert, K A Jones.   

Abstract

The structure of the mouse 5-HT3 receptor gene, 5-HT3R-A, is most similar to nicotinic acetylcholine receptor (nAChR) genes, in particular to the gene encoding the neuronal nAChR subunit alpha 7. These genes share among other things the location of three adjacent introns, suggesting that 5-HT3R-A and nAChR genes arose from a common precursor gene. The alternative use of two adjacent splice acceptor sites in intron 8 creates, in addition to the original 5-HT3R-A cDNA (5-HT3R-AL), a shorter isoform (5-HT3R-AS) which lacks six codons in the segment that translates into the major intracellular domain. This splice consensus sequence is not found in human genomic DNA. In mouse, we demonstrate by RNAse protection assay that 5-HT3R-AS mRNA is approximately 5 times more abundant than 5-HT3R-AL mRNA in both neuroblastoma cell lines and neuronal tissues. We used the Semliki Forest virus expression system for electrophysiological characterization of 5-HT3R-AS and 5-HT3R-AL in mammalian cells. No differences in electrophysiological characteristics, such as voltage dependence, desensitization kinetics, or unitary conductance were found between homomeric 5-HT3R-AS and 5-HT3R-AL receptors. Their properties are very similar to those of 5-HT3 receptors in mouse neuroblastoma cell lines.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7854052     DOI: 10.1016/0169-328x(94)90095-7

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  16 in total

1.  The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors.

Authors:  Karla P Zeitz; Nicolas Guy; Annika B Malmberg; Sahera Dirajlal; William J Martin; Linda Sun; Douglas W Bonhaus; Cheryl L Stucky; David Julius; Allan I Basbaum
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

Review 2.  Therapeutics of 5-HT3 receptor antagonists: current uses and future directions.

Authors:  Tina K Machu
Journal:  Pharmacol Ther       Date:  2011-02-26       Impact factor: 12.310

3.  Open probability of homomeric murine 5-HT3A serotonin receptors depends on subunit occupancy.

Authors:  D D Mott; K Erreger; T G Banke; S F Traynelis
Journal:  J Physiol       Date:  2001-09-01       Impact factor: 5.182

4.  Functional characterization of two 5-HT3 receptor splice variants isolated from a mouse hippocampal cell line.

Authors:  M Glitsch; E Wischmeyer; A Karschin
Journal:  Pflugers Arch       Date:  1996-05       Impact factor: 3.657

5.  Improvements in hippocampal-dependent learning and decremental attention in 5-HT(3) receptor overexpressing mice.

Authors:  Amber V Harrell; Andrea M Allan
Journal:  Learn Mem       Date:  2003 Sep-Oct       Impact factor: 2.460

Review 6.  The 5-HT3 receptor--the relationship between structure and function.

Authors:  Nicholas M Barnes; Tim G Hales; Sarah C R Lummis; John A Peters
Journal:  Neuropharmacology       Date:  2008-08-12       Impact factor: 5.250

7.  Influence of sodium substitutes on 5-HT-mediated effects at mouse 5-HT3 receptors.

Authors:  M Barann; K Schmidt; M Göthert; B W Urban; H Bönisch
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

8.  High affinity binding of epibatidine to serotonin type 3 receptors.

Authors:  Renaldo C Drisdel; Douglas Sharp; Tricia Henderson; Tim G Hales; William N Green
Journal:  J Biol Chem       Date:  2007-08-15       Impact factor: 5.157

9.  Actions of general anaesthetics on 5-HT3 receptors in N1E-115 neuroblastoma cells.

Authors:  A Jenkins; N P Franks; W R Lieb
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

10.  Large scale transient 5-HT3 receptor production with the Semliki Forest Virus Expression System.

Authors:  H D Blasey; B Brethon; R Hovius; H Vogel H; A P Tairi; K Lundström; L Rey; A R Bernard
Journal:  Cytotechnology       Date:  2000-03       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.